Tofase 5 contains Tofacitinib (5 mg) a JAK inhibitor used for the treatment of moderate to severe rheumatoid arthritis and other autoimmune disorders. By selectively inhibiting specific enzymes Tofacitinib helps reduce inflammation joint pain and stiffness enhancing patients’ overall quality of life and mobility. This formulation is effective for those who may not respond well to traditional therapies offering a modern approach to managing chronic inflammatory conditions.
Reviews
There are no reviews yet.